Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
NVO Key Statistics
NVO News
For Immediate Release Chicago, IL – April 25, 2024 – Today, Zacks Equity Research discusses Eli Lilly LLY, Novo Nordisk NVO, Merck MRK and AbbVie ABBV. Indust...
Novo Nordisk (NVO) has released an update. Novo Nordisk A/S has updated its Articles of Association, maintaining a commitment to research, development, and com...
Novo Nordisk (NVO) has released an update. Novo Nordisk A/S has announced a reduction in its B share capital following the Annual General Meeting decision on M...
Analyst ratings
66%
of 32 ratingsMore NVO News
CNN — Sen. Bernie Sanders is taking aim at the high prices of the blockbuster drugs Ozempic and Wegovy. The Vermont senator, an independent who has long calle...
In the latest trading session, Novo Nordisk (NVO) closed at $126.16, marking a -1.93% move from the previous day. This change lagged the S&P 500's daily gain of...
Dale Folwell says North Carolina is “under siege” by drugmakers Novo Nordisk and Eli Lilly. The North Carolina treasurer said the sky-high costs of popular wei...
U.S. Sen. Bernie Sanders sent letter on Wednesday to Novo Nordisk CEO Lars Fruergaard Jørgensen announcing that the Senate Committee on Health, Education, Labor...
Senator Bernie Sanders is set to lead a Senate investigation into the high prices charged by Novo Nordisk for its diabetes and anti-obesity medications Ozempic...
A key Senate committee on Wednesday launched an investigation into how Novo Nordisk (NVO) (OTCPK:NONOF) prices its popular weight loss drug semaglutide in the U...
Loading... Loading... The Senate Committee on Health, Education, Labor, and Pensions is reportedly scrutinizing Novo Nordisk A/S NVO ‘s pricing strategies, par...
